Vernalis PLC (LSE:VER) - Share price - Overview

Stock Report

Vernalis PLC VER

Last Price
GBX18.13

Day Change
0.00|0.00%

As of 25/05/2017
14:13:08 BST | GBX
Minimum 15 Minutes Delay.

Last Close18.13p
Day Range17.75 - 17.84
Mkt Cap95.38Mil
52-Wk Range16.00 - 49.75
Yield %0.00
ISINGB00B3Y5L754
Volume7,920
P/E-5.72
P/S6.86
P/CF-4.02

Share Price

Total Returns 25/05/2017

 Chg (%)  
More ...
Vernalis PLC-11.59 
FTSE 100 TR GBP4.01
 
Financials
201420152016
More ...
Income Statement
Turnover-13.2912.03
Operating Profit--7.91-23.57
Net Profit--4.28-14.50
Reported EPS--0.94-3.20
Balance Sheet
Current Assets-71.5192.54
Non Current Assets-15.0719.95
Total Assets-86.58112.49
Current Liabilities-5.227.71
Total Liabilities-9.479.76
Total Equity-77.11102.73
Cash Flow
Operating Cash Flow--8.11-23.55
Net Change in Cash--7.05-12.59
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-26.74-4.81--3.77---
2018-31.55-5.73--3.16---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
12/10/2016Exercise of OptionIan Garland1.0091,310913.00
12/10/2016Sale of Option SharesDavid Mackney39.0727,23310,640.00
12/10/2016Exercise of OptionDavid Mackney1.0048,630486.00
30/09/2016Transfer inMs. Carol Ferguson0.0028,0000.00

Company Profile

Vernalis PLC is a development stage pharmaceutical company. The Company develops products for the U.S prescription cough and cold market.

Sector

Biotechnology

Market Position

931 of 1852 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(21/02/2017) no outlook statement

Next Event 30/06/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-3.2114.9816.74
Div Yld (E)0.003.614.05
PEG (E)0.000.410.91
ROCE-17.71186.32-70.22
Op Mrgn-150.38-7.71-98.41
EPS Grwth0.0057.8428.49
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy4
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Peter Fellner
Chief Executive OfficerIan Garland
Chief Financial OfficerDavid Mackney
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.